TREM2 and Alzheimer disease: We therefore examined whether the triggering receptor expressed on myeloid cells 2 (Trem2), a transmembrane receptor explicitly expressed in brain microglia and known AD risk gene regulating microglial activity34–36, was differentially regulated in DKI-HFHS mice.